Skip to content

effect of of glucose on bleeding during cesarean section

Evaluation of the effect of preoperative administration of glucose on intra and postoperative bleeding during cesarean section under spinal anesthesia

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20100102002963N39
Enrollment
60
Registered
2025-09-21
Start date
2025-09-23
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bleeding during cesarean section. Postpartum hemorrhage

Interventions

Intervention 1: Intervention group: 25 Grams of glucose (equivalent to 500 cc of 5% glucose serum) + Half a liter of Ringer's solution before surgery. Intervention 2: Control group: 500 cc of normal s

Sponsors

Yazd University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 35 Years

Inclusion criteria

Inclusion criteria: pregnancy ASA class 2 Candidate for non-emergency cesarean section due to second repeat cesarean section term pregnancy

Exclusion criteria

Exclusion criteria: Patient's unwillingness to participate in the study eclampsia preeclampsia diabetes mellitus hypertension cardiac disease lung disease kidney disease liver disease Drug and psychotropic addiction

Design outcomes

Primary

MeasureTime frame
Reducing bleeding during cesarean section. Timepoint: Hemoglobin is measured and recorded before and six hours after the procedure Also, the amount of bleeding during the operation is assessed by counting blood gases, the amount of suctioned blood, and the estimated volume of blood in the veins and the results are recorded in a questionnaire. The amount of bleeding during recovery is also assessed by estimating the amount of blood in the patient's pad. Method of measurement: Laboratory.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Shekoufeh Behdad

Yazd University of Medical Sciences

drbehdad@ssu.ac.ir+98 35 3823 1932

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026